학술논문
Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand
Document Type
Article
Author
Source
In: Drug Safety . (Drug Safety, September 2023, 46(9):867-879)
Subject
Language
English
ISSN
11791942
01145916
01145916